Summary CKD has been linked with cognitive deficits and affective disorders in multiple studies. Analysis of structural and functional neuroimaging in adults and children with kidney disease may provide additional important insights into the pathobiology of this relationship. This paper comprehensively reviews neuroimaging studies in both children and adults. Major databases (PsychLit, MEDLINE, WorldCat, ArticleFirst, PubMed, Ovid MEDLINE) were searched using consistent search terms, and studies published between 1975 and 2012 were included if their samples focused on CKD as the primary disease process. Exclusion criteria included case reports, chapters, and review articles. This systematic process yielded 43 studies for inclusion (30 in adults, 13 in children). Findings from this review identified several clear trends: (1) presence of cerebral atrophy and cerebral density changes in patients with CKD; (2) cerebral vascular disease, including deep white matter hyperintensities, white matter lesions, cerebral microbleeds, silent cerebral infarction, and cortical infarction, in patients with CKD; and (3) similarities in regional cerebral blood flow between patients with CKD and those with affective disorders. These findings document the importance of neuroimaging procedures in understanding the effect of CKD on brain structure, function, and associated behaviors. Results provide a developmental linkage between childhood and adulthood, with respect to the effect of CKD on brain functioning across the lifespan, with strong implications for a cerebrovascular mechanism contributing to this developmental linkage. Use of neuroimaging methods to corroborate manifest neuropsychological deficits or perhaps to indicate preventive actions may prove useful to individuals with CKD.
Introduction
Kidney function may affect brain function on many levels, ranging from developmental alterations and vascular injury to disorders of metabolism. There is increasing interest in understanding the neurologic basis of cognitive and affective dysfunction in children and adults with kidney disease that is evident in neurobehavioral findings across the lifespan (e.g., increased rates of neurocognitive impairments in children; increased rates of dementia in adults). Neuroimaging methods provide a noninvasive means of examining brain structure and function (1) and represent an important approach for further elucidating the kidney-brain connection in individuals with CKD. Sixteen years ago, Butler et al.
(2) touted the benefits of using magnetic resonance angiography as a screening tool for cerebral aneurysms and subarachnoid hemorrhage in patients with autosomal dominant polycystic kidney disease (ADPKD). Similarly, Burn and Bates (3) reviewed neurologic presentations in patients with a wide range of kidney diseases (e.g., Von Hippel-Lindau disease) from genetic predisposition to tumors to direct and indirect effects of kidney disease on brain functioning.
To date, several comprehensive reviews have examined the neuroimaging literature in individuals with CKD. Aǧildere et al. (4) provided one of the first reviews of the neurologic complications of ESRD in patients undergoing hemodialysis (HD) assessed by use of magnetic resonance imaging (MRI). These investigators highlighted the importance of MRI, including T2-weighted, fluid-attenuated inversion recovery, and proton density images, as a tool for clinical investigation of ESRD-associated neurologic symptoms. They reported that patients with ESRD, particularly those receiving HD, have high rates of neurologic complications compared with healthy controls. They surveyed the use of MRI in combination with new and conventional imaging methods for diagnosing white matter changes, cerebral atrophy, osmotic demyelination syndrome, dialysis encephalopathy, hypertensive encephalopathy, intracranial hemorrhage, cerebral ischemia and infarction, infection, and sinus thrombosis.
Brouns and De Deyn (5) also reviewed the causes and presentations of neurologic complications in uremic patients with ESRD. They noted that dialysis and renal transplantation themselves may precipitate neurologic symptoms and that treatment and maintenance for patients with ESRD should address both renal and neurologic components. More recently, Lakadamyali and Ergün (6) reviewed brain MRI findings for diagnosis of acute neurologic complications in patients with ESRD undergoing HD. They noted that symptoms may be caused directly by CKD itself, HD, or a combination of the two. Cerebral ischemia and infarction, intracerebral hemorrhage, posterior reversible encephalopathy syndrome, osmotic demyelination syndrome, cerebral infection, gadolinium accumulation, sinus vein thrombosis, and dialysis disequilibrium syndrome are all reported as being detected via MRI. Vogels et al. (7) reviewed the association between CKD and brain lesions as noted on MRI and computed tomography (CT). They reported association of CKD with brain atrophy, silent cerebral infarction, and white matter lesions (WMLs).
Taken together, these earlier reviews describe the neurologic complications that can stem from CKD. Importantly, however, none of these reviews provide findings pertaining to children. In addition, the earlier reviews focused on specific neurologic complications from CKD and did not provide a broad overview of the neuroimaging literature related to CKD.
This paper provides an updated review of neuroimaging in kidney disease, focusing on quantitative findings from both structural and functional neuroimaging studies in children and adults. The primary objective is to provide a contemporary summary of the available studies. Analysis of structural and functional neuroimaging in adults and children with kidney disease will provide additional important insights into the pathobiology of CKD.
Methods
A systematic review of major search databases was conducted to compile a comprehensive list of studies that used neuroimaging techniques in individuals with CKD and were published between 1975 and 2012. Three reviewers systematically reviewed databases, including PsychLit, Ovid MEDLINE, MEDLINE, WorldCat, PubMed, and ArticleFirst. Designated search terms included MRI AND chronic kidney disease, computed tomography AND hemofiltration, polycystic kidney AND brain AND magnetic resonance imaging, dialysis AND single-photon emission computed tomography (SPECT), dialysis AND MRI, dialysis AND regional cerebral blood flow (rCBF), rCBF AND CKD, CKD AND CT, dialysis AND transcranial Doppler, dialysis AND cerebral magnetic resonance imaging, neurologic impairment in CKD, neuroimaging AND CKD, and diffusion tensor imaging (DTI) AND CKD. Studies were included in the review if (1) the sample focused on CKD (defined by an estimated GFR [eGFR] ,60 ml/min per 1.73 m 2 for $3 months) as the primary disease process and (2) the study produced quantitative statistics. Exclusion criteria included case reports, book chapters, and previous review articles.
Use of the search terms in this systematic process produced 1462 possible articles, and an additional 9 records were identified through other sources (e.g., citations included in the ascertained articles). Removal of the duplicate articles resulted in a pool of 1264 potential articles for inclusion. Application of the inclusion and exclusion criteria produced 43 articles for inclusion in the review. These studies comprised 30 studies in adults (20 structural, 10 functional) and 13 studies in children (13 structural). The selection and identification process for candidate studies can be seen in Figure 1 .
Results

Adult Neuroimaging Studies
Thirty studies included adults with CKD in their neuroimaging protocols: 20 structural and 10 functional. These studies span a time frame from 1987 (8) to 2011 (9) (10) (11) . The study designs included retrospective, cross-sectional, casecontrol, and prospective approaches to data collection. Sample sizes ranged widely, and the composition of the CKD samples reflected significant heterogeneity across studies. Other studies examined AKI (e.g., Ronco et al. 12); however, our review focuses on CKD. For the structural neuroimaging studies, the primary technique used was MRI, with several studies using CT. For the functional neuroimaging studies, the primary techniques used were SPECT, transcranial Doppler ultrasonography, and rCBF using 133 Xe inhalation.
Findings in Adult Structural Neuroimaging Studies
In adults, more severe kidney disease has been associated with abnormal structural findings. One study has documented the presence of intracranial arachnoid cysts in ADPKD (13) , but more studies examined MRI findings in patients undergoing various renal replacement therapies (RRTs) and have reported the presence of cerebral atrophy and decreased cerebral density in both white and gray matter (9, (14) (15) (16) (17) (18) (19) (20) (21) . Walters et al. (18) showed that five HD patients had postdialysis increases in cerebral volume compared with five controls. Savazzi et al. (20) found high correlations between atrophy on CT and MRI and predialytic BP. Yoshimitsu et al. (19) also studied MRI in HD patients and reported significantly more lacunae and more advanced periventricular hyperintensity than matched controls. In one of the largest studies conducted to date (187 kidney transplant and 29 liver transplant cases), Aǧildere et al. (16) found that roughly one third of adult renal transplant recipients had neuroradiologic findings on MRI, including nearly 20% of patients with hemispheric sulcal and ventricular dilatation.
Similar findings have been uncovered in patients not receiving RRT. In neuroimaging studies conducted to date, with sample sizes ranging from 52 to 625 adult cases with CKD, high rates of structural abnormalities were detected with MRI, including WMLs (22) . In a study by Wada et al. (23) , elderly patients with CKD (defined by low eGFR [,60 ml/min per 1.73 m 2 ] or a urinary albumin-to-creatinine ratio .30 mg/g) evidenced more lacunar infarcts and higher grades of WMLs. After adjustment for hypertension and diabetes, CKD continued to remain an independent risk factor for cerebrovascular disease-related lesions. Several other investigators have reported similar findings (24) (25) (26) (27) . Using DTI, Kim et al. (9) showed subtle WMLs in a small sample of patients receiving peritoneal dialysis (PD).
Cerebral small vessel disease has also been studied in the adult CKD population. Kobayashi et al. (28) found that decreased kidney function was a risk factor for silent lacunar infarcts. The prevalence of silent cerebral infarction also has been reported to be significantly higher in HD patients than in controls (17) . Kobayashi et al. (29) also found an independent association between silent cerebral infarction and decreased kidney function, and silent cerebral infarction independently predicted outcomes, including stroke and dementia. Other investigators have asserted that WMLs reflect possible ischemic brain damage and generalized vascular damage, and both are independently associated with vascular nephropathy in patients with CKD (22) . In patients with CKD, high rates of cerebral microbleeds have also been documented, with rates ranging from about 26% (30) to 61% (29) . These microbleeds tended to be more prevalent in male patients, those with hypertension, those with advanced age, and those with worsening kidney function as defined by eGFR, with no relation to the use of antiplatelet or antithrombotic therapy (15, 30, 31) . Table 1 summarizes the adult structural neuroimaging studies in CKD.
Findings in Adult Functional Neuroimaging Studies
Functional neuroimaging studies use methods to detect structural brain abnormalities and localized neural activity in reaction to executing certain specific sensory, motor, and cognitive tasks. These studies are sensitive to changes in rCBF and blood flow velocity in targeted brain regions. Seven of the 10 studies included in this review focused on patients receiving HD or PD. In one of the oldest imaging studies conducted with adults, which used 133 Xe inhalation, Gottlieb et al. (8) found that predialysis rCBF values did not differ from those in age-matched controls; however, after HD, there was a mild but significant reduction in rCBF. This reduction was not associated with cognitive impairment or neurologic symptoms. Using transcranial Doppler ultrasonography, several studies have documented similar findings. Prohovnik et al. (32) showed that 19 HD patients had reduced rCBF between sessions. Other investigators have reported similar findings (33, 34) , with blood flow reductions noted in the middle cerebral artery and the basilar artery after HD (35) . However, some studies report contrary findings, suggesting that cerebral blood flow does not change significantly during or after HD (36) . Many functional neuroimaging studies also have used SPECT in their examination of blood flow velocities images) The prevalence of SCI was significantly higher in HD patients than in healthy controls (P,0.0001). For both groups, independent risk factors for SCI were chronic renal failure, hypertension, smoking, and age. In the HD group, age and smoking were independent risk factors of SCI (P,0.0001), whereas HD duration and hypertension were not. and subcortical white matter hyperintensity; PD, peritoneal dialysis; DTI, diffusion-tensor imaging; SBI, silent brain infarct; eGFR, estimated GFR; CMB, cerebral microbleeds; EHT, essential hypertension; WML, white matter lesions; HD, hemodialysis; SCr, serum creatinine; Ccr, creatinine clearance; SCI, silent cerebral infarct; VBR, ventricular-brain ratio; CT, computed tomography; PTH, parathyroid hormone; CA, cerebral atrophy; CHD, coronary heart disease; ADPKD, autosomal dominant polycystic kidney disease. Discrete cortical defects consistent with infarcts were seen in 14 patients (82%). The defects were found in all lobules. The mean right and left frontal-to-cerebellar ratios were not significantly different from the right and left temporal-to-cerebellar ratios, and both were within normally accepted ranges, suggesting no evidence of Alzheimer-type dementia. CT, computed tomography; MRI, magnetic resonance imaging; EEG, electroencephalography; ABER auditory brainstem evoked response; CNS, central nervous system; HD, hemodialysis; SLE, systemic lupus erythematosus; CAPD, continuous ambulatory peritoneal dialysis; PD, peritoneal dialysis; SCr, serum creatinine.
in adults with CKD. Lass et al. (37) documented discrete cortical defects consistent with infarcts in 82% of their heterogeneous patient sample (patients with CKD and those undergoing dialysis), with the defects being observable in each of the lobules. Although magnetic resonance spectroscopy does not assess rCBF, it provides indices that help elucidate neurochemical functions within the brain. To date one study has assessed magnetic resonance spectroscopy in adults with CKD. Using magnetic resonance spectroscopy in HD patients, patients with stage 4 and 5 CKD, and matched healthy controls, Tryc et al. (11) reported reduced brain activity, as defined by targeted neurometabolites related to healthy brain functioning (i.e., choline, N-acetylaspartate, and N-acetylaspartylglutamate), in HD patients. Additionally, memory/learning and attention impairments were observed in both nondialyzed and dialyzed patients with CKD, but more severe cognitive dysfunction and neurometabolic alterations were seen in HD patients than in those with CKD stages 4 and 5.
Finally, the relationship between CKD and depression in adults also has received attention in the neuroimaging literature. Kim et al. (14) demonstrated that in 27 patients with CKD, rCBF patterns correlated with symptom clusters of depressive mood. These findings were similar to those in individuals with major depressive disorder without CKD (38) and patients with Parkinson disease and depression (39) . More recently, Nam et al. (10) studied 14 patients with CKD before and 6 months after HD and found correlations between reduced levels of depression, higher perfusion in the left middle temporal gyrus, and higher rCBF in the right parahippocampal gyrus. These latter findings implicate the importance of the kidneybrain connection not only in the neurologic aspect of cognition and learning but also in the affective presentation of many individuals with CKD, particularly with respect to the appearance of affective disorders. Table 2 summarizes the adult functional neuroimaging studies in CKD.
Pediatric Neuroimaging Studies
Thirteen studies included children with CKD in their neuroimaging protocols. Unlike the adult studies, all of the pediatric studies to date have been of a structural nature. These studies span from 1977 (40) to 2006 (41) . The study designs included retrospective, cross-sectional, case-control, and prospective approaches to data collection. Sample sizes ranged widely, with the composition of the CKD samples reflecting significant heterogeneity across studies. For the structural neuroimaging studies, all of the pediatric investigations used CT, and several studies also used MRI.
Findings in Pediatric Structural Neuroimaging Studies
As with adults, cerebral atrophy has been noted in children with ESRD, and this appears to be more prevalent in the HD population. Passer (40) was one of the first few to publish neuroimaging findings in ESRD. Thirty-three patients with ESRD secondary to various causes underwent head CT as part of their predialysis evaluation. This group of patients ranged widely in age and included children. Cerebral atrophy was noted in ESRD, with the degree of atrophy correlating with the age of onset. Similar findings have been reported by other investigators (42) (43) (44) using solely pediatric samples; Qvist et al. (45) documented the presence of cerebral atrophy even after transplant in 15% of their cases.
Papageorgiou et al. (46) conducted a similar comparative study of brain atrophy in patients with CKD and those undergoing long-term HD age 16-70 years compared with age-matched controls. None of the patients had clinical signs of uremic encephalopathy. Compared with their age-matched controls, the renal patients had significantly enlarged ventricles, with the greatest enlargement noted in the HD group. Using a small sample of pediatric patients who developed CKD at birth, Elzouki and colleagues (47) found that approximately 23% showed cerebral atrophy. Enlarged ventricles, a correlate of brain atrophy, have also been reported by investigators studying primarily pediatric samples; estimates were significantly higher and ranged from 59% (44) to 67% (43) . In addition, enlarged cortical sulci have been reported on cranial CT in up to 80% of pediatric cases with cystinosis (48) . Widening of cerebrospinal fluid spaces secondary to brain atrophy (42) , with lower cerebral density, has been typically associated with HD (43, 49) in comparison with patients receiving continuous ambulatory PD (50) . In general, the literature suggested that although brain atrophy was evident in patients with stable CKD and those receiving continuous ambulatory PD, it was definitely more frequent in HD patients.
In addition to cerebral atrophy, brain lesions have also been documented using both CT and MRI. Specifically, Ishikura et al. (41) studied 20 cases of posterior reversible encephalopathy syndrome. In most patients, radiologic abnormalities extended to the gray matter (85%), particularly in the frontal and temporal lobes, and the cerebellum. Moreover, ischemic lesions have been documented in the vascular border zones at a rate of about 54% in children who received a renal transplant before 5 years of age (45, 51) . Cortical infarcts have been documented after transplant as well (44, 45) . These findings, however, also showed the presence of various neurologic deficits (e.g., brain infarcts, cerebral atrophy) and other factors (e.g., history of hemodynamic crisis, prematurity, congenital nephrosis), including hypercoagulability related to long-term PD before transplantation, suggesting a priori brain insults during the first 5 years of life (51) . Table 3 summarizes the pediatric structural neuroimaging studies in CKD.
Discussion
This review of the neuroimaging literature in CKD provides a contemporary examination of one important facet of the kidney-brain connection: namely, structural and functional neuroimaging studies in CKD. This review complements earlier reviews conducted on this topic but to our knowledge is the first to include both pediatric and adult studies and to focus on the structural and functional findings in the brain.
This review focused on understanding potential linkages between kidney disease and brain structural and functional integrity across the lifespan. As can be seen in Table 4 , several clear findings emerged. In addition to clustering studies under four major themes, Table 4 shows the sample composition for these studies. The three substantive themes are presented below.
Cerebral Atrophy and Cerebral Density Changes Are Found in Children and Adults With CKD Both cerebral atrophy and cerebral density changes have been noted in CKD, particularly with more severe kidney disease. These findings were seen more frequently in both child and adult patients on intermittent dialysis treatments (long-term HD, intermittent PD) than in patients with CKD (who were not receiving dialysis) or patients undergoing continuous veno-venous hemofiltration (CVVH). These changes were present in adults but were more marked during the periods of cerebral development in children. These findings were not necessarily associated with the presence of neurologic signs or symptoms, but up to 59% of these cases were noted to have brain atrophy (44) . Recurrent osmotic changes of the brain during HD and aluminum toxicity (in older studies) were associated with a greater risk for brain atrophy in HD patients. The degree of brain atrophy also has been related to predialytic BP and the duration of hypertension. Even after transplantation, the prevalence of cerebral atrophy is at least 15%-20%.
Similarly, significant changes in cerebral density have been discovered in both children and adults with CKD, with changes reported after HD but not after CVVH. These findings favor continuous RRTs, such as CVVH, to avoid this effect; however, this is not a viable treatment option for long-term outpatient dialysis therapy. In general, these findings support the ongoing study of more frequent and/ or intensive dialysis regimens, in place of HD three times a week (52) .
Signs of Cerebral Vascular Disease Are Seen in Children and Adults with CKD
Both kidney and brain are highly vascularized organs and may share sensitivity to vascular disease. Accordingly, the brains of patients with CKD tend to show confluent deep white matter hyperintensities, WMLs, cerebral microbleeds, and territorial cerebral infarcts. ESRD, chronologic age, and hypertension appear to be significant predictors of the presence of abnormal subcortical white matter. These findings indicate how kidney disease and its sequelae lead to cerebrovascular disease through microangiopathy (23) . Further, vascular nephropathy was found to be the most important factor related to the presence of these lesions, suggesting that WMLs may reflect ischemic brain damage secondary to generalized vascular damage. Conversely, stage and duration of CKD have not been linked to the presence of WMLs.
CKD has been related to small vessel disease-related lesions. Lower eGFR levels and albuminuria were associated with more lacunar infarcts and higher grades of WMLs and less white matter volume. These findings were present after adjustment for age, sex, and cardiovascular factors and when individuals with stage 2 hypertension, cardiovascular risk factors, or diabetes were excluded from examination (23, 25) . Similarly, the incidence of cerebral microbleeds appears to be high in patients receiving maintenance HD, with rates hovering around 25%-35% (31) . These findings point to poor renal function as a significant risk factor for cerebral microbleeds as well as for future cerebrovascular events. It is interesting to know that although no relationship between anticoagulants and cerebral microbleeds has been uncovered in adults, this relationship has not been studied in pediatric patients.
Further evidence from these studies points to the presence of cerebral infarctions as being present in CKD, serving as yet another marker of possible cerebrovascular disease. The prevalence of silent cerebral infarctions has been shown to be at least 50% in patients with ESRD (40) . Among causes of CKD, hypertensive nephrosclerosis had a strong association with silent brain infarctions, and lower/declining eGFR, chronologic age, and hypertension were independently associated with a higher prevalence of silent brain infarction. Taken together, these neuroimaging findings point to CKD as an independent risk factor for these infarctions and provide a strong linkage to the risk for cerebrovascular disease.
Finally, in adults receiving HD, blood flow velocities in the middle cerebral artery and the basilar artery immediately before and after HD are significantly reduced after dialysis treatment (32) . Functional imaging techniques, such as transcranial Doppler ultrasonography, should be considered to monitor rapid changes in cerebral circulation during HD treatments. To date, no studies have investigated blood flow velocities in children with CKD, although such studies may provide early clues for the later appearance of cerebrovascular disease.
Functional Brain Imaging Techniques Show Circulatory Patterns Consistent with Affective Disorders
For adults, the available neuroimaging studies suggest that rCBF patterns in CKD are similar to those seen in patients with major depressive disorder without CKD. Conversely, improvement in depressive symptoms has been associated with higher perfusion in the left middle temporal gyrus and higher rCBF in the right parahippocampal gyrus (10, 14) . To date, no such studies have been conducted with children and adolescents with CKD.
Summary
This comprehensive review has analyzed structural and functional neuroimaging in adults and children with kidney disease. This review points to several key evidencebased findings supporting the ongoing study of the kidneybrain connection, with noteworthy findings indicating the presence of cortical atrophy and other structural differences in both children and adults with CKD, particularly with increasing disease burden and the need for RRT, and while controlling for other disease-related factors. The findings also provided evidence suggesting developmental continuity of cerebrovascular involvement in both children and adults with CKD. These latter studies point to cerebrovascular disease as one primary mechanism for the appearance of abnormal brain structure, impaired brain functions, and perhaps increasing cognitive impairments across the lifespan.
Despite the overarching nature of the available studies, it is important to note that our systematic review also revealed several limitations that moderate the strength of the findings. The corpus of studies spans approximately 35 years, with 30 of the 43 studies involving adults. The number of pediatric studies is increasing, but to date no published functional imaging studies have directly examined brain function in children and adolescents with CKD. Further, many of the earlier pediatric studies actually include both adults and children in their samples, thus obscuring the effects of CKD in child brain structure and function. Study designs ranged widely but largely used cross-sectional approaches to patient ascertainment; this raises issues of how CKD, and its changing degree of severity, interacts with neurodevelopmental aspect of brain structure and function over time. Additionally, very few longitudinal studies have been conducted with adults or children. Only a small subset of the included studies focused on functional neuroimaging. Finally, most of the studies were conducted with small and/or heterogeneous samples of individuals with CKD and RRT, although there were some notable exceptions in the structural neuroimaging literature for adults.
In the future, it will be of interest to expand studies to link complications of CKD, such as hypertension and bone mineral disorder, with neuroimaging. One such study of interest is the ongoing, National Institutes of Healthsponsored SPRINT-MIND (Systolic Blood Pressure Intervention Trial-Memory and Cognition in Decreased Hypertension) study, which will determine whether a lower systolic BP goal will further reduce the risk of cardiovascular and kidney disease or age-related cognitive decline. Future pediatric study designs should aim at recruiting pure CKD population (with no history of prematurity, underlying central nervous system abnormalities, or genetic disorders) because that will permit study of the kidney-brain connection with perhaps more careful consideration. The use of neuroimaging procedures as part of routine clinical care requires ongoing investigation, but these findings do point to the use of such procedures for cases showing neurologic symptoms. Their use from a preventive stance for young patients with CKD also holds promise with respect to managing their cerebrovascular health and associated neurologic morbidity across the lifespan.
